Coronary Arterial Disease (CAD)
Conditions
Keywords
coronary artery disease, virtual reality, treatment adherence
Brief summary
This randomized controlled trial aims to evaluate the effects of nurse-led branching scenario-based education delivered through virtual reality and tablet on cardiovascular disease risk awareness and adherence to antiplatelet medication in patients with coronary artery disease. Participants will be randomly assigned to a virtual reality education group, a tablet-based education group, or a control group receiving routine hospital education. Cardiovascular disease risk awareness and medication adherence will be assessed before and after the educational intervention and during follow-up.
Interventions
BEHAVIORALVirtual Reality-Based Branching Scenario Education
Participants will first complete a pre-test assessment. They will then receive nurse-led coronary artery disease education through an interactive, branching scenario-based educational program delivered using a virtual reality (VR) headset. The educational content includes visual, interactive, and scenario-based learning activities, with different learning pathways and feedback based on participants' choices. Following the educational intervention, participants will complete a post-test assessment.
BEHAVIORALTablet-Based Branching Scenario Education
Participants will first complete a pre-test assessment. They will then receive nurse-led coronary artery disease education through an interactive, branching scenario-based educational program delivered using a tablet. The educational content includes visual, interactive, and scenario-based learning activities, with different learning pathways and feedback based on participants' choices. Following the educational intervention, participants will complete a post-test assessment.
Sponsors
Abant Izzet Baysal University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Aged 18-65 years. * Diagnosed with coronary artery disease. * Newly initiated on antiplatelet therapy. * Conscious and able to communicate. * Physically and cognitively able to use a virtual reality headset. * Able to read, write, and understand Turkish. * Willing to provide written informed consent. * Willing to participate in the education and follow-up process. * Has not previously received education about coronary artery disease. * Able to use a smartphone.
Exclusion criteria
* Cognitive impairment or mental illness preventing communication. * Visual or hearing impairment preventing participation in the virtual reality education. * Participation in another clinical study at the same time. * Diagnosis of malignant disease. * Bleeding disorder or active bleeding risk. * Hospitalization within the previous 3 months due to acute myocardial infarction, stroke, or another serious cardiovascular event. * Unable to understand the educational materials. * Refusal to provide written informed consent.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| cardiovascular disease risk awareness assessment scale score | baseline and immediately after the educational intervention | Change in cardiovascular disease risk awareness, assessed using the Turkish validated 22-item Cardiovascular Disease Risk Awareness Assessment Scale (CVD-RAAS). The knowledge domain score ranges from 0 to 8, with higher scores indicating higher knowledge about myocardial infarction and stroke. The total score for the 14-item Likert-type awareness subscales ranges from 14 to 56, with higher scores indicating greater awareness of cardiovascular disease risks, healthier dietary intentions, and higher readiness for behavioral change. |
| medication adherence report scale score | Baseline, immediately after the intervention, and 3 months follow-up | Change in medication adherence, assessed using the Turkish validated 5-item Medication Adherence Report Scale (MARS-5). Each item is scored on a 5-point Likert scale (1 = always to 5 = never). Total scores range from 5 to 25, with higher scores indicating greater medication adherence. |
| Cardiovascular Disease Risk Awareness Assessed by the Cardiovascular Disease Risk Awareness Assessment Questionnaire | Baseline, immediately after the intervention, and 3 months after the intervention. | Cardiovascular disease risk awareness will be assessed using the Turkish version of the Cardiovascular Disease Risk Awareness Assessment Questionnaire (CDRAAQ), a 22-item instrument consisting of an 8-item knowledge section and three subscales: perceived risk of heart attack/stroke, healthy eating intentions, and perceived benefits and intentions to change. The knowledge items are scored as correct or incorrect, with each correct response receiving 1 point. The subscale items are rated on a 4-point Likert scale from 1 (strongly disagree) to 4 (strongly agree), with reverse scoring applied where appropriate. Higher scores indicate greater cardiovascular disease risk awareness, greater knowledge of heart attack and stroke, and greater readiness for health-related behavioral change. |
Countries
Turkey (Türkiye)
Contacts
CONTACTSaadet Can Çiçek, PhD
Outcome results
None listed